Showing titles in Biotechnology

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

A gripping journey of discovery, The Catalyst moves from the early experiments that first hinted at RNA's spectacular powers, to Cech's own paradigm-shifting finding that it can catalyze cellular reactions, to the cutting-edge biotechnologies poised to reshape our health.

The cells in our bodies consist of molecules, made up of the same carbon, oxygen, and hydrogen atoms found in air and rocks. But molecules, such as water and sugar, are not alive. So how do our cells - assemblies of otherwise "dead" molecules - come to life, and together constitute a living being? In Life’s Ratchet, physicist Peter M. Hoffmann locates the answer to this age-old question at the nanoscale.

In 24 thought-provoking lectures designed for nonscientists, this course explores today's exciting field of genomics, the study of the vast storehouse of information contained within chromosomes. Your professor is Princeton University biologist Lee M. Silver, an acclaimed teacher, scientist, and author of popular books on biotechnology, genetics, and their impact on society.

Millions of data enthusiasts from around the world compete on Kaggle, the most famous data science competition platform of them all. Participating in Kaggle competitions is a surefire way to improve your data analysis skills, network with an amazing community of data scientists, and gain valuable experience to help grow your career. The first audiobook of its kind, The Kaggle Book assembles in one place the techniques and skills you'll need for success in competitions, data science projects, and beyond.

Shortly after the emergence of genetic engineering in the 1970s, academic biologists were courted by venture capitalists and multinational companies. Researchers who understood the new biology of the time went from being merely curious about how the natural world functioned to realizing that they could profit from their newfound recognition. As they were inventing all sorts of newfangled organisms, biologists became acquainted with intellectual property.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. Biotech will mean that we can live far better, safer, healthier, wealthier, happier, and longer lives.

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

Few people know much about stem cell research beyond the ethical questions raised by using embryos. But in the last decade, stem cell research has made huge advances toward eliminating some of our most intractable diseases. Now this sweeping and accessible book introduces us to this cutting-edge science, which will revolutionize medicine and change the way we think about and treat disease.

Hay una revolución en marcha, una tecnología prodigiosa que nos va a permitir curar enfermedades, derrotar virus y tener hijos más sanos. A su cabeza está la reciente premio Nobel Jennifer Doudna y sus colegas, protagonistas del nuevo libro de Walter Isaacson.

A lo largo del último siglo, la humanidad ha logrado lo imposible frenando la hambruna, la peste y la guerra. Por primera vez en la historia, más personas mueren por obesidad que por pasar hambre y hay más probabilidades de quitarse la vida que de morir en un conflicto bélico o un atentado terrorista.

This audiobook uncovers the biggest scientific fraud of our age. It tells the fascinating and frequently astounding story of how the massive enterprise to restructure the genetic core of the world's food supply came into being, how it advanced by consistently violating the protocols of science, and how for more than three decades, hundreds of eminent biologists and esteemed institutions have systematically contorted the truth in order to conceal the unique risks of its products - and get them onto our dinner plates.

James T. Bradley introduces important biological principles and the basic procedures used in biotechnology. Various ethical issues - personhood, personal identity, privacy, ethnic discrimination, distributive justice, authenticity and human nature, and the significance of mortality in the human life cycle - are presented in a clear and unbiased manner.

At a conference in Hong Kong in November 2018, Dr. He Jiankui announced that he had created the first genetically modified babies - twin girls named Lulu and Nana - sending shockwaves around the world. A year later, a Chinese court sentenced Dr. He to three years in prison for "illegal medical practice". As scientists elsewhere start to catch up with China's vast genetic research program, gene editing is fueling an innovation economy that threatens to widen racial and economic inequality. Fundamental questions about science, health, and social justice are at stake.

In 2010, scientists led by J. Craig Venter became the first to successfully create "synthetic life" - putting humankind at the threshold of the most important and exciting phase of biological research, one that will enable us to actually write the genetic code for designing new species to help us adapt and evolve for long-term survival. The science of synthetic genomics will have a profound impact on human existence, including chemical and energy generation, health, clean water and food production, environmental control, and possibly even our evolution.

Ein Blick durch das Schlüsselloch der Forschungslabore und Hightech-Firmen: Woran sie arbeiten, was sie planen, was jetzt schon möglich ist. Spitzenforscher sind sich einig: Auch mit Mitte 90 noch fit zu sein, kann Standard werden. Und 120 Jahre Leben wird für viele Menschen erreichbar – schon für die jetzt geborenen Generationen. Doch was müssen wir tun, um nicht nur länger zu leben, sondern auch länger gesund zu bleiben? Thomas Schulz, langjähriger SPIEGEL-Korrespondent im Silicon Valley, hat mit Konzernchefs und Spitzenforscherinnen, AI-Koryphäen und Medizinerinnen gesprochen.

This gripping narrative explores today's scientific pursuit of immortality, with exclusive visits inside Silicon Valley labs and interviews with the visionaries who believe we will soon crack into the aging process and cure death. We live in an age when billionaires are betting their fortunes on laboratory advances to prove aging unnecessary and death a disease that can be cured.

The introduction of new medicines has dramatically improved the quantity and quality of individual and public health, while contributing trillions of dollars to the global economy. In spite of these past successes - and indeed because of them - our ability to deliver new medicines may be quickly coming to an end. Moving from the 20th century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.

A panoramic overview of biotechnologies that can endlessly boost human capabilities and the drastic changes these "superhuman" traits could trigger. Biotechnology is moving fast. In the coming decades, advanced pharmaceuticals, bioelectronics, and genetic interventions will be used not only to heal the sick but to boost human physical and mental performance to unprecedented levels.